Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,224.8
20.2 (0.63%)

 

  • STI Straits Times Index
    3,224.8
    20.2 (0.63%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.0
    -1.2 (-0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,610.1
    -428.2 (-1.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,562.3
    -35.3 (-0.98%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,098.2
    -7.8 (-0.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,607.3
    -49.6 (-0.75%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,129.0M
  • Value: 683.3M
  • Rise: 178
  • Fall: 123
  • Unch: 450

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Tritech0.027+0.004
Koh Eco0.066+0.009
Raffles Edu0.068+0.009
Vividthree0.065+0.020
Boldtek0.113+0.004
GKE0.148+0.009
ThaiBev0.725+0.010
Zhongxin Fruit0.049+0.004
Hatten Land0.062-0.001
Progen0.053+0.002

World Indices

World Indices
Name Last Change
Nasdaq 15,235.7 +9.0
HSI 25,610.9 -427.4
HSCEI 9,089.2 -170.2
Jakarta 6,606.8 -50.1
Nikkei 225 29,098.2 -7.8
SSE Comp 3,562.3 -35.3
Shanghai A 3,733.4 -37.1
Shanghai B 276.1 -1.2
KOSPI 3,025.5 -23.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EDESA BIOTECH INC EDESA BIOTECH
Updated on 26 Oct 2021 (End of trading day)
Last (USD): 7.720 Change: -0.260 High: 7.970 Remarks: -
Change (%): -3.26 Low: 7.700
Open 7.910 Yesterday's Close 7.9799999999999995
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 276,927 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.48012 Trailing EPS (USD) e -0.88050 NAV (USD) b 1.1922
PE a - Trailing PE f - Price / NAV b 6.4754
Dividend (USD) d - Cash In Hand (USD) g 0.6075 Issued & Paid-up Shares c 13,255,600
Dividend Yield (%) d - Price / Cash In Hand g 12.708 Treasury Shares h -
Market Cap (M) 102.333 Enterprise Value (M) 94.402
Piotroski F Score 2 Exchange Code EDSA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.60 Free Float (%) 63.8
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 20 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Jun 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EDESA BIOTECH INC NASDAQ 102.333 - - 6.4754 -
Industry Pharmaceuticals: Major NASDAQ 2,319.942 86.391 91.614 3.3631 0.026
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 192,898.290 60.356 51.153 12.3053 1.865
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 126,245.922 8.993 18.230 1.6834 -
Local Peer ROYALTY PHARMA PLC NASDAQ 22,914.671 23.501 23.586 3.9965 0.508
Local Peer VIATRIS INC NASDAQ 16,301.229 - - 0.7687 -
Local Peer REPLIGEN CORP NASDAQ 15,054.407 251.216 150.645 9.3910 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 7,933.878 - - 9.7313 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 7,564.201 - - 22.2530 -
Local Peer CUREVAC NV NASDAQ 7,245.820 - - - -
Local Peer ALLAKOS INC NASDAQ 6,041.668 - - 10.5811 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,665.866 - - 19.2793 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 5,470.018 - - 5.5545 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 4,887.125 71.631 71.631 5.6797 -
Other Local Peers KARUNA THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), KRONOS BIO INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), GH RESEARCH PLC (NASDAQ), PETIQ INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANNEXON INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), VERU INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), AC IMMUNE SA (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), 89BIO INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CLENE INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), NEXIMMUNE INC (NASDAQ), ATHENEX INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), XOMA CORP (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), DURECT CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), TRICIDA INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMMUNIC INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), OBSEVA SA (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), MUSTANG BIO INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), ALZAMEND NEURO INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), LANTERN PHARMA INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), EYENOVIA INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), MEDIWOUND LTD (NASDAQ), IMARA INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), GALECTO INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), RENOVORX INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), BAUDAX BIO INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), SEQLL INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 436,333.560 29.654 24.403 - 2.401
Global Peer PFIZER INC NYSE 244,227.416 25.398 18.463 3.4869 3.488
Global Peer ELI LILLY AND COMPANY NYSE 237,652.984 38.370 39.148 36.8775 1.191
Global Peer MERCK & CO INC NYSE 208,205.182 29.462 37.373 6.2535 3.014
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 206,536.193 25.587 22.989 3.8218 2.272
Global Peer ABBVIE INC NYSE 193,488.538 42.469 29.365 15.3940 4.415
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 190,284.316 29.530 26.729 18.2002 1.253
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 129,415.686 - - 3.5160 3.190
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 101,087.657 13.712 17.043 4.7587 5.150
Global Peer WUXI APPTEC CO LTD HKEx 480,364.305 144.733 103.731 10.8810 0.216
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), INNOVENT BIOLOGICS INC (HKEx), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), ORGANON & CO (NYSE), CANSINO BIOLOGICS INC (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), REMEGEN CO LTD (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), AKESO INC (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ADC THERAPEUTICS SA (NYSE), SHANGHAI HENLIUS BIOTECH INC (HKEx), EVEREST MEDICINES LTD (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), SSY GROUP LIMITED (HKEx), OCUMENSION THERAPEUTICS (HKEx), CSTONE PHARMACEUTICALS (HKEx), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ZYMEWORKS INC (NYSE), IMMUNOTECH BIOPHARM LTD (HKEx), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), ABBISKO CAYMAN LTD (HKEx), Kimia Farma Tbk. (IDX), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), CK LIFE SCIENCES INTL HLDG (HKEx), ANTENGENE CORP LTD (HKEx), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), TRANSCENTA HOLDING LTD (HKEx), HUA MEDICINE (HKEx), Soho Global Health Tbk. (IDX), ZHAOKE OPHTHALMOLOGY LTD (HKEx), IGBB (Bursa), RACE ONCOLOGY LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), STARPHARMA HOLDINGS LIMITED (ASX), TOT BIOPHARM INTL CO LTD (HKEx), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), CYBIN INC (NYSE American), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), ANNOVIS BIO INC (NYSE American), IP (SET), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), IX Biopharma (SGX), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), RECCE PHARMACEUTICALS LTD (ASX),